Leukocytoclastic vasculitis secondary to erysipelas: An unusual case of noncryoglobulinemic vasculitis in a hepatitis C patient

Journal of Clinical Rheumatology

Volumn 19, Issue 5, 2013, Pages 282-283

  Goel, Gaurav ^a   Fomberstein, Barry ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; PEGINTERFERON ALPHA2A; RIBAVIRIN; TELAPREVIR;

ADULT; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; BLOOD CELL COUNT; CASE REPORT; COUGHING; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE DURATION; ERYSIPELAS; ERYTHEMA; FACE; FEVER; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ABUSE; LABORATORY TEST; LEUKOCYTOCLASTIC VASCULITIS; LEUKOCYTOSIS; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RASH; SKIN BIOPSY; SKIN DEFECT; SORE THROAT; SYMPTOM; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; ERYSIPELAS; FACE; HEPATITIS C; HUMANS; MALE; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS;

EID: 84881479400     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31829cf41a     Document Type: Article

References (7)

1. Buezo GF, García-Buey M, Rios-Buceta L, et al. Cryoglobulinemia and cutaneous leukocytoclastic vasculitis with hepatitis C virus infection. Int J Dermatol. 1996;35:112-115.
2. Groves C, Devereux C, McMillan C. A case of cutaneous vasculitis with underlying hepatitis C and cryoglobulinaemia. Ulster Med J. 2008;77:51-53.
3. Belizna CC, Hamidou MA, Levesque H, et al. Infection and vasculitis. Rheumatology. 2009;48:475-482.
4. Sánchez Yus E, Iglesias Díez L. Etiopathogenesis of necrotizing arteritis (leukocytoclastic vasculitis). Allergol Immunopathol (Madr). 1976;4:269-278.
5. Margolin L. Leukocytoclastic vasculitis associated with bullous erysipelas. Int J Dermatol. 2003;42:300-301.
6. Cacoub P, Saadoun D. Hepatitis C virus infection induced vasculitis. Clin Rev Allergy Immunol. 2008;35:30-39.
7. Papageorgiou NJ, Tassopoulos N. Mixed cryoglobulinemia and HCV. Annals of Gastroenterology. 2002,15:36-40.